These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33887987)

  • 1. Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers.
    Lai MH; Liao CH; Tsai NM; Chang KF; Liu CC; Chiu YH; Huang KC; Lin CS
    Cancer Control; 2021; 28():10732748211009245. PubMed ID: 33887987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
    Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
    Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers.
    Tsang YW; Liao CH; Ke CH; Tu CW; Lin CS
    J Pers Med; 2021 Sep; 11(10):. PubMed ID: 34683090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.
    Hughes TD; Güner OF; Iradukunda EC; Phillips RS; Bowen JP
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
    Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.
    Jin H; Zhang Y; You H; Tao X; Wang C; Jin G; Wang N; Ruan H; Gu D; Huo X; Cong W; Qin W
    Sci Rep; 2015 Jun; 5():10466. PubMed ID: 26099564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
    Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L
    J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics.
    Maddison DC; Alfonso-Núñez M; Swaih AM; Breda C; Campesan S; Allcock N; Straatman-Iwanowska A; Kyriacou CP; Giorgini F
    PLoS Genet; 2020 Nov; 16(11):e1009129. PubMed ID: 33170836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of kynurenine 3-monooxygenase inhibition.
    Amaral M; Levy C; Heyes DJ; Lafite P; Outeiro TF; Giorgini F; Leys D; Scrutton NS
    Nature; 2013 Apr; 496(7445):382-5. PubMed ID: 23575632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.
    Wilson K; Mole DJ; Binnie M; Homer NZ; Zheng X; Yard BA; Iredale JP; Auer M; Webster SP
    Protein Expr Purif; 2014 Mar; 95(100):96-103. PubMed ID: 24316190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer.
    Liu CY; Huang TT; Chen JL; Chu PY; Lee CH; Lee HC; Lee YH; Chang YY; Yang SH; Jiang JK; Chen WS; Chao Y; Teng HW
    Front Oncol; 2021; 11():620361. PubMed ID: 33937026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase.
    Poda SB; Kobayashi M; Nachane R; Menon V; Gandhi AS; Budac DP; Li G; Campbell BM; Tagmose L
    Assay Drug Dev Technol; 2015 Oct; 13(8):466-75. PubMed ID: 26292018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.
    Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ
    Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
    Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
    J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases.
    Zhang S; Collier MEW; Heyes DJ; Giorgini F; Scrutton NS
    Arch Biochem Biophys; 2021 Jan; 697():108702. PubMed ID: 33275878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors.
    Chiu YH; Lei HJ; Huang KC; Chiang YL; Lin CS
    J Oncol; 2019; 2019():6201764. PubMed ID: 31186637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
    Swaih AM; Breda C; Sathyasaikumar KV; Allcock N; Collier MEW; Mason RP; Feasby A; Herrera F; Outeiro TF; Schwarcz R; Repici M; Giorgini F
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.